06/05/2026
You may qualify to take part in this study if you are 18 to 80 years old and:
• Have a diagnosis of active psoriatic arthritis.
• Have a diagnosis of active plaque psoriasis or history of plaque psoriasis.
• Don’t have any other kind of arthritis or inflammatory joint disease.
• Have psoriatic arthritis that has not gotten better from non-biologic disease-modifying antirheumatic drugs (DMARDs, such as methotrexate, sulfasalazine, leflunomide, and apremilast), or from biologic disease-modifying antirheumatic drugs (bDMARDs, adalimumab, etanercept, secukinumab, risankizumab), or are intolerant of these medications.
There are additional requirements that determine whether you may qualify to be in this study. The study doctor will discuss this with you.